The Asia-Pacific DNA Vaccine market is anticipated to grow at a CAGR 42.3% during the forecast period. Asia-Pacific has the significant market of DNA vaccine due to increasing awareness about the benefits and flexibility offered by DNA vaccines. Major economies contributing in the market are China, Japan, India, South Korea and Thailand. Factors such as growing prevalence of cancer, unhealthy lifestyle, increasing disposable income, increasing awareness among people toward vaccination are the major factors that are motivating the market. Some of the key players contributing in the growth of DNA vaccine market include Bharat Biotech, Geneone Life Sciences Inc., LG Life sciences and among others.